ProMIS Neurosciences Inc. , a clinical-stage biotechnology company focused on developing precision therapies for neurodegenerative diseases, today announced the initiation of its Phase 1b clinical ...
The researchers found that a biomarker in the blood called neurofilament light chain (NfL) increased after menopause. This ...
The following is a summary of “Effect of siponimod on retinal thickness, a marker of neurodegeneration, in participants with SPMS: Findings from the EXPAND OCT substudy,” published in the January 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback